NCT05918185 2026-02-03
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Mayo Clinic
Completed
Clinical Trials
3 trialsNCT03941860 2025-05-23
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
National Cancer Institute (NCI)
Phase 3 Completed
NCT03119883 2024-08-09
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
Mayo Clinic
Phase NA Completed